ARTICLE | Financial News
Corvus slips in first trading day
March 24, 2016 12:58 AM UTC
Immuno-oncology company Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) lost $0.75 to $14.25 in its first day of trading Wednesday after it raised $70.5 million in an IPO. The company priced at the bottom of its $15-$17 range (see BioCentury Extra, March 22). ...